Molecular basis of complement activation by ficolins throu the lectin pathsay
纤维胶蛋白通过凝集素途径激活补体的分子基础
基本信息
- 批准号:12470079
- 负责人:
- 金额:$ 8.96万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Discrimination between self and non-self by lectins is a strategy of innate immunity that is found in both vertebrates and invertebrates. In vertebrates, immune recognition is mediated by ficolins as well as mannose-binding lectin (MBL). Ficolins are the proteins characterized by the presence of an N-terminal collagen-like domain and a C-terminal fibrinogen-like domain, and have been identified in mammalians such as pig, mouse and human. In this project, human L-and H-ficolins were found to form complexes with MASPs, Cis-like serine proteases and sMAP, a truncated form of MASP-2. Upon recognition of carbohydrate patterns on invading microorganisms by these ficolins, the associated MASPs were activated to cleave the complements C3/C4 through the lectin complement pathway. L-ficolin recognized lipteicholic acid and 1,3-β-D glucan, components in the cell wall of microorganisms, as well as N-acetylglucosamine residue on glycoproteins. To further clarify the physiological roles of ficolins and MASPs/sMAP we established ficolin A-deficient and Maspi-deficient mice using gene targeting technique. The phenotype of ficolin A-dificient mice is now under investigation. Masp-1 deficient mice were more susceptible for infection by influenza virus. Sera from Masp 1-deficient mice showed low activation of Masp-2 from the proenzyme form, followed by a delay of complement activation. To explore primitive system of the lectin pathway, ficolins and the other components of the lectin pathway were isolated from lower animals such as ascidian Halocynthia rorezti, our closest invertebrate relatives. The system was suggested to be simply consisted of three components, recognition molecules (ficolin-like and MBL-like lectins), MASP and complement C3. These results suggest that ficolins have a pivotal role as recognition molecules for host defense in all species which emerged after ascidians.
在脊椎动物和无脊椎动物中,自我和非自我歧视是一种免疫力。 C末端纤维蛋白原样结构域在该项目中。通过这些纤维蛋白,将相关的masps激活,通过凝集素补体裂解C3/C4。 SMAP我们建立了ficolin a缺陷型和Maspi缺陷的靶向技术。 -2通过补体激活的延迟,探索凝集素途径的原始系统。结果表明,纤维蛋白具有关键作用,作为在海沿岸出现的所有物种中宿主防御的识别分子。
项目成果
期刊论文数量(188)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Matsushita M, Fujita T: "The roles of ficolins in innate immunity"Immunolobiology. 205(4-5). 490-497 (2002)
Matsushita M,Fujita T:“纤维胶蛋白在先天免疫中的作用”免疫生物学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
OSAWA I., et al.: "Cryoprecipitate of patients with cryoglobulinemic glomerulonephritis contains molecules of the lectin complement pathway"Clin.Immunol.. 101. 59-66 (2001)
OSAWA I. 等人:“冷球蛋白血症性肾小球肾炎患者的冷沉淀含有凝集素补体途径的分子”Clin.Immunol.. 101. 59-66 (2001)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
MATSUSHITA M., et al.: "Ficolins and the Lectin Complement Pathway"Immunol.Rev.. 180. 78-85 (2001)
MATSUSHITA M.等人:“Ficolins 和凝集素补体途径”Immunol.Rev.. 180. 78-85 (2001)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Shikuya A.: "Fcα/μ-u receptor mediates endocytosis of IgM-coated microbes"Nature Immunology. 1. 441-446 (2000)
Shikuya A.:“Fcα/μ-u 受体介导 IgM 包被微生物的内吞作用”《自然免疫学》1. 441-446 (2000)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
ENDO M., et al.: "Complement Activation through the Lectin Pathway in Patients with Henoch-Schonlein Purpura Nephrits"Am.J.Kidney Des.. 35. 401-407 (2000)
ENDO M. 等人:“过敏性紫癜肾病患者通过凝集素途径进行补体激活”Am.J.Kidney Des.. 35. 401-407 (2000)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUJITA Teizo其他文献
FUJITA Teizo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FUJITA Teizo', 18)}}的其他基金
The lectin complement pathway is involved in activation of the alternative pathway
凝集素补体途径参与旁路途径的激活
- 批准号:
21390086 - 财政年份:2009
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Roles of host defense lectin.s in innate immunity
宿主防御凝集素在先天免疫中的作用
- 批准号:
13143204 - 财政年份:2001
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
A novel lectin-dependent activation pathway of complement
一种新的凝集素依赖性补体激活途径
- 批准号:
07044285 - 财政年份:1995
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for international Scientific Research
A NOVEL LECTIN-DEPENDENT ACTIVATION PATHWAY OF COMPLEMENT
一种新型的凝集素依赖性补体激活途径
- 批准号:
06454223 - 财政年份:1994
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A novel lectin-dependent activation pathway of complement
一种新的凝集素依赖性补体激活途径
- 批准号:
06044189 - 财政年份:1994
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for international Scientific Research
Production of chimeric protein to scavenge immune complexes
产生嵌合蛋白以清除免疫复合物
- 批准号:
02557026 - 财政年份:1990
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
相似国自然基金
凝集素类受体蛋白激酶OsLecRK-S.7通过磷酸化OsRBOH6调控水稻花药发育的分子机制研究
- 批准号:32370362
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
罗非鱼鼠李糖凝集素基因(OnRBL)介导柱状黄杆菌粘附侵染的分子机制
- 批准号:32303046
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
绵羊甘露聚糖结合凝集素(MBL)在MO人工感染中致病性减弱的作用机制研究
- 批准号:32360812
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
凝集素高亲和糖载体吸入粉雾剂表面微结构的定向构建及其肺部感染增效治疗机制研究
- 批准号:82373802
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
单分子力谱成像及定量细胞表面多糖-凝集素相互作用
- 批准号:22364017
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Decay accelerating factor (CD55) protects against lectin pathway-mediated AT2 cell dysfunction in cigarette smoke-induced emphysema
衰变加速因子 (CD55) 可防止香烟烟雾引起的肺气肿中凝集素途径介导的 AT2 细胞功能障碍
- 批准号:
10990669 - 财政年份:2024
- 资助金额:
$ 8.96万 - 项目类别:
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
- 批准号:
10751872 - 财政年份:2024
- 资助金额:
$ 8.96万 - 项目类别:
Elucidating mechanisms underlying multivalency modulating lectin-glycan binding and assembly properties-implications for lectin function regulation
阐明多价调节凝集素-聚糖结合和组装特性的机制-对凝集素功能调节的影响
- 批准号:
BB/Y005856/1 - 财政年份:2024
- 资助金额:
$ 8.96万 - 项目类别:
Research Grant
Role of CD44 bearing TJA-II binding glycans in therapy-resistant subset of triple negative breast cancer
携带 CD44 的 TJA-II 结合聚糖在三阴性乳腺癌耐药亚型中的作用
- 批准号:
23K06748 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)